News
There is increased risk for major gastrointestinal bleeding with edoxaban vs VKA therapy in patients with atrial fibrillation following TAVR.
Abbott is doubling down on the structural heart space as it aims to gain ground in valve replacements following the recent ...
The global transcatheter heart valve replacement (TAVR) market is estimated to be valued at USD 8.18 billion in 2025 and is projected to reach USD 32.82 billion by 2035, registering a compound annual ...
The prosthetic heart valve market is expected to reach USD 15,294.6 million by 2025 and grow at a compound annual growth rate (CAGR) of 7.5% to reach USD 31,522.6 million by 2035. The prosthetic ...
At Sanford Health in Bismarck, doctors have now performed 500 transcatheter aortic valve replacements, known as TAVR.
The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results